Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nontoxic MMP inhibitor from Pharmacia with antitumor activity

July 16, 2001

Exelixis delivers cancer antibody targets to PDL for further development

July 16, 2001

Neutrophil elastase inhibitor prevents cancer metastasis in animal model

July 16, 2001

Idec submits additional information for Zevalin BLA

July 16, 2001

New Photofrin indication filed with Canadian authorities

July 16, 2001

Tie2 receptor kinase inhibitors useful for angiogenic disorders

July 13, 2001

EntreMed begins enrollment of initial patients in phase I/II study of rhEndostatin

July 13, 2001

Use of PRAC protein in cancer Rx available for licensing from NIH

July 13, 2001

Promising phase III trial results reported with Leuprogel three-month depot

July 11, 2001

Aventis transfers selected product rights to Introgen Therapeutics through investment

July 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...